Literature DB >> 7711724

Fine deletion mapping on the long arm of chromosome 9 in sporadic and familial basal cell carcinomas.

S M Shanley1, H Dawkins, B J Wainwright, C Wicking, P Heenan, M Eldon, J Searle, G Chenevix-Trench.   

Abstract

Basal cell carcinomas (BCCs) are the most common sporadic cancers worldwide. They are also a cardinal manifestation of a familial cancer predisposition syndrome, naevoid BCC syndrome (NBCCS). The gene responsible for NBCCS is likely to be a tumour suppressor gene and has been genetically mapped to a 2cM region between microsatellite markers, D9S196 and D9S180 at 9q22.3-q31. 101 BCCs (63 sporadic and 38 familial) were examined for loss of heterozygosity (LOH) in the candidate region of the NBCCS gene. Deletions were found in 46% and all LOH is consistent with genetic mapping of the NBCC locus. These findings strongly support the hypothesis that inactivation of the putative tumour suppressor, the NBCCS gene, is important in the formation of sporadic BCCs. One sporadic tumour indicates that the smallest region of overlap of these deletions is within the interval between D9S287 and D9S180. If this is confirmed in additional tumours, it would further narrow down the NBCCS region and exclude one candidate gene, that for the C complementation group of Fanconi anaemia, which maps proximally to D9S287. However, it would not exclude another candidate, the gene for the A complementation group of xeroderma pigmentosum (XPAC). Evidence of imprinting was also sought but preliminary data indicate that it is unlikely to occur at the NBCCS locus.

Entities:  

Mesh:

Year:  1995        PMID: 7711724     DOI: 10.1093/hmg/4.1.129

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  6 in total

1.  Molecular analysis of chromosome 9q deletions in two Gorlin syndrome patients.

Authors:  R Shimkets; M R Gailani; V M Siu; T Yang-Feng; C L Pressman; S Levanat; A Goldstein; M Dean; A E Bale
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

2.  Recessive oncogenes: current status.

Authors:  Xiang Gao; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

3.  Mutational landscape of basal cell carcinomas by whole-exome sequencing.

Authors:  Shyam S Jayaraman; David J Rayhan; Salar Hazany; Michael S Kolodney
Journal:  J Invest Dermatol       Date:  2013-06-17       Impact factor: 8.551

4.  Evidence for two candidate tumour suppressor loci on chromosome 9q in transitional cell carcinoma (TCC) of the bladder but no homozygous deletions in bladder tumour cell lines.

Authors:  A A van Tilborg; L E Groenfeld; T H van der Kwast; E C Zwarthoff
Journal:  Br J Cancer       Date:  1999-05       Impact factor: 7.640

5.  Differential allele loss on chromosome 9q22.3 in human non-melanoma skin cancer.

Authors:  E Holmberg; B L Rozell; R Toftgård
Journal:  Br J Cancer       Date:  1996-07       Impact factor: 7.640

6.  High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci.

Authors:  J Devlin; P A Elder; H Gabra; C M Steel; M A Knowles
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.